Eosinophilic fasciitis (Shulman disease): New insights into the therapeutic management from a series of 34 patients

Rheumatology

Volumn 51, Issue 3, 2012, Pages 557-561

  Lebeaux, David ^a,b   Francés, Camille ^b,c   Barete, Stéphane ^b,c   Wechsler, Bertrand ^a,b   Dubourg, Odile ^a,b   Renoux, Jérôme ^a,b   Maisonobe, Thierry ^a,b   Benveniste, Olivier ^a,b   Gatfossé, Marc ^d   Bourgeois, Pierre ^a,b   Amoura, Zahir ^a,b   Cacoub, Patrice ^a,b   Piette, Jean Charles ^a,b   Séne, Damien ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL TENON   (France)

^d Centre Hospitalier Coulommiers   (France)

Author keywords

Eosinophilia; Fasciitis; Methotrexate; Morphoea; Treatment

Indexed keywords

AZATHIOPRINE; COLCHICINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DELAYED DIAGNOSIS; DISABILITY; EOSINOPHILIC FASCIITIS; FEMALE; HUMAN; HYPEREOSINOPHILIA; MALE; MORPHEA; MUSCLE BIOPSY; MYALGIA; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SKIN BIOPSY; TREATMENT FAILURE; TREATMENT RESPONSE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; AZATHIOPRINE; COLCHICINE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISONE; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SYNOVITIS; TREATMENT OUTCOME;

EID: 84857588548     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker366     Document Type: Article

References (16)

1. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol 1974;11:569-70.
2. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975;88: 70-86.
3. Endo Y, Tamura A, Matsushima Y et al. Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 2007;26: 1445-51.
4. Lakhanpal S, Ginsburg WW, Michet CJ et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17: 221-31.
5. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 2008; 47:29-35.
6. Bukiej A, Dropinski J, Dyduch G et al. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol 2005;24:634-6.
7. De Jonge-Bok JM, Steven MM, Eulderink F et al. Diffuse (eosinophilic) fasciitis. A series of six cases. Clin Rheumatol 1984;3:365-73.
8. Khanna D, Agrawal H, Clements PJ. Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases. Rheumatology 2010;49: 1184-8.
9. Nassonova VA, Ivanova MM, Akhnazarova VD et al. Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol 1979;8:225-33.
10. Scheinberg M, Hamerschlak N, Kutner JM et al. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004). Clin Exp Rheumatol 2006; 24:65-9.
11. Smith LC, Cox NH. Dapsone treatment for eosinophilic fasciitis. Arch Dermatol 2008;144:845-7.
12. Zulian F, Athreya BH, Laxer R et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology 2006; 45:614-20.
13. Heidary N, Cheung W, Wang N et al. Eosinophilic fasciitis/generalized morphea overlap. Dermatol Online J 2009;15:2.
14. Moulin C, Cavailhes A, Balme B et al. Morphoea-like plaques revealing an eosinophilic (Shulman) fasciitis. Clin Exp Dermatol 2009;34:e851-3.
15. Kreuter A, Gambichler T, Breuckmann F et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005;141:847-52.
16. Uziel Y, Feldman BM, Krafchik BR et al. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000;136:91-5.